Expression of insulin-like growth factor-I in lesional and non-lesional skin of patients with morphoea

British Journal of Dermatology

Volumn 159, Issue 1, 2008, Pages 86-90

  Fawzi, M M T ^a   Tawfik, S O ^a   Eissa, A M ^a   El Komy, M H M ^a   Abdel Halim, M R E ^a   Shaker, O G ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Growth factors; Insulin like growth factor I; Morphoea; Scleroderma; Sclerosis

Indexed keywords

SOMATOMEDIN C;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MORPHEA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SKIN BIOPSY; SKIN DEFECT;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; SCLERODERMA, LOCALIZED;

EID: 45749088459     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08592.x     Document Type: Article

References (25)

1. Yu BD, Eisen AZ. Scleroderma. In : Dermatology in General Medicine (Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, eds 6th edn. New York : McGraw-Hill, 2003 1709 18.
2. Kissin EY, Korn JH. Fibrosis in scleroderma. Rheum Dis Clin North Am 2003 29 : 351 69.
3. LeRoy EC. Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest 1974 54 : 880 9.
4. Raoul JM, Verma M, Tan E et al. Cytokines as therapeutic targets for the gastrointestinal manifestations of scleroderma. Can J Gastroenterol 2004 18 : 22 4.
5. Tsai CH, Yang SF, Chen YJ et al. The upregulation of insulin-like growth factor-I in oral submucous fibrosis. Oral Oncol 2005 41 : 940 6.
6. Colao A, Barkan AL, Scarpa R. Growth hormone/insulin-like growth factor-I system and connective tissues: basic aspects and clinical implications. Rheum Dis Clin North Am 2005 31 : 29 42.
7. Noble PW, Lake FR, Henson PM et al. Hyaluronate activation of CD44 induces insulin-like growth factor-I expression by a tumour necrosis factor-alpha dependent mechanism in murine macrophages. J Clin Invest 1993 91 : 2368 77.
8. Arkins S, Rebeiz N, Brunke-Reese DL et al. The colony-stimulating factors induce expression of insulin-like growth factor I messenger ribonucleic acid during hematopoiesis. Endocrinology 1995 136 : 1153 60.
9. Arkins S, Rebeiz N, Brunke-Reese DL et al. Interferon-gamma inhibits macrophage insulin-like growth factor I synthesis at the transcriptional level. Mol Endocrinol 1995 9 : 350 60.
10. Krein PM, Winston BW. Roles for insulin-like growth factor I and transforming growth factor-β in fibrotic lung disease. Chest 2002 122 : S289 93.
11. Makower AM, Skottner A, Wroblewski J. Binding of the insulin-like growth factor I (IGF-I) to primary cultures of chondrocytes from rat rib growth cartilage. Cell Biol Int Rep 1989 13 : 655 65.
12. Tsuji Y, Kinoshita Y, Hato F et al. The in vitro proliferation of thymus epithelial cells stimulated with growth hormone and insulin-like growth factor I. Cell Mol Biol 1994 40 : 1135 42.
13. Landreth K, Narayanan R, Dorshkind K. Insulin-like growth factor I regulates pro-B cell differentiation. Blood 1992 80 : 1 6.
14. Gibson LF, Piktel D, Landreth KS. Insulin-like growth factor I potentiates expansion of interleukin-7-dependent pro-B cells. Blood 1993 82 : 3005 11.
15. Robbins K, McCabe S, Scheiner T et al. Immunological effects of insulin-like growth factor I: enhancement of immunoglobulin synthesis. Clin Exp Immunol 1994 95 : 337 42.
16. Harrington EA, Bennett MR, Fanidi A et al. CMyc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 1994 13 : 3286 95.
17. Krein PM, Huang Y, Winston BW. Growth factor regulation and manipulation in wound repair: to scar or not to scar, that is the question. Expert Opin Ther Patents 2001 11 : 1 15.
18. Lasky JA, Brody AR. Interstitial fibrosis and growth factors. Environ Health Perspect 2000 108 (Suppl. 751 62.
19. Clements PJ, Lachenbruch PA, Ng SC et al. Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum 1990 33 : 1256 63.
20. Baumgarter TA, Strong CH. Conducting and Reading Research in Health and Human Performance, 2nd edn. New York : McGraw-Hill, 1998.
21. Barreca A, De Luca M, Del Monte P et al. In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors. J Cell Physiol 1992 151 : 262 8.
22. Thiebaud D, Ng KW, Findlay DM et al. Insulin-like growth factor I regulates mRNA levels of osteonectin and pro-alpha-I(i)-collagen in clonal proosteoblastic calvarial cells. J Bone Miner Res 1990 5 : 761 7.
23. Rothe MJ, Altman RD, Falanga V. Plasma somatomedin-C levels in systemic sclerosis. Br J Dermatol 1988 119 : 639 42.
24. Shinohara M, Hamasaki Y, Katayama I. Refractory pretibial myxoedema with response to intralesional insulin-like growth factor I antagonist (octreotide): downregulation of hyaluronic acid production by the lesional fibroblasts. Br J Dermatol 2000 143 : 1083 6.
25. Pavlovic M, Saiag P, Lotz JP et al. Regression of sclerodermatous skin lesions in a patient with carcinoid syndrome treated by octreotide. Arch Dermatol 1995 131 : 1207 8.